WEBINAR VIDEO | Navigating Mergers and Acquisitions in Life Sciences: Insights for Success and Pitfalls to avoid
During this webinar, the experts from our assembled transactions team, Richard Liu, Mieke D’hanis and Pauline Geentjens, provide valuable insights, inform you of common pitfalls and let you in on a number of tips and tricks during an M&A process.
Contact us
Recommended articles
The Mons Labour Court’s addition of a new condition for the validity of a non-solicitation clause : the beginning of a new era?
In a recently-published judgment [1] the Mons Labour Court has shed new light on the validity of a so-called non-solicitation clause in an employment contract, i.e. a clause prohibiting an employee from soliciting or enticing away customers and/or personnel from the (former) employer. Where certain case law had already pointed out in the past that, […]
Read on
Three months’ protection indemnity for a dismissed DPO
In a recent judgment,[1] the French-speaking section of the Brussels Labour Court confirmed that a Data Protection Officer (DPO) may not be penalised or dismissed for reasons related to his/her function as a DPO, based on Article 38, §3 of the GDPR. The court ruled that the employer had violated this provision as it had failed to prove that the employment contract’s termination was not linked to the employee's DPO role...
Read on
The new Belgian government’s public health policy: 10 key take-aways for pharma policy
The new Belgian federal government has outlined its vision for public health in a policy paper under the slogan “More money for health, more health for our money”. Public health is a high-priority sector with a significant budget, and the policy paper introduces several key measures that will shape the pharmaceutical industry in the coming years. For pharma companies operating in Belgium, these developments bring both new regulatory challenges and strategic opportunities. Here is a focused analysis of ten key changes and their potential impact on the pharma industry.
Read on